Clinical trial
Minocycline to Treat Childhood Regressive Autism
NCT00409747 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00409747 |
|---|---|
| Title | Minocycline to Treat Childhood Regressive Autism |
| Official title | Treatment of Childhood Regressive Autism With Minocycline: an Anti-Inflammatory Agent Active Within the CNS |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Autism, Minocycline, Regressive Autism |
| Intervention type | Drug |
| Interventions | Minocycline |
| Enrollment | 11 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2010 |
| Completion | Apr 1, 2011 |
| First posted | Dec 11, 2006 |
| Last update posted | Dec 11, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: